Gregory Piazza

11.2k total citations · 3 hit papers
160 papers, 4.0k citations indexed

About

Gregory Piazza is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Gregory Piazza has authored 160 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Internal Medicine, 81 papers in Cardiology and Cardiovascular Medicine and 37 papers in Surgery. Recurrent topics in Gregory Piazza's work include Venous Thromboembolism Diagnosis and Management (127 papers), Atrial Fibrillation Management and Outcomes (52 papers) and Acute Myocardial Infarction Research (29 papers). Gregory Piazza is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (127 papers), Atrial Fibrillation Management and Outcomes (52 papers) and Acute Myocardial Infarction Research (29 papers). Gregory Piazza collaborates with scholars based in United States, Italy and France. Gregory Piazza's co-authors include Samuel Z. Goldhaber, John Fanikos, Umberto Campia, Ida Ehlers Albertsen, Mark A. Creager, David A. Morrow, David M. Dudzinski, Romain Chopard, Jean M. Connors and Marie Gerhard‐Herman and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Gregory Piazza

149 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism

2018 303 citations Gregory Piazza, Samuel Z. Goldhaber et al. profile →
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study

2022 108 citations Gregory Piazza, Samuel Z. Goldhaber et al. profile →
Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE)

2024 27 citations Samuel Z. Goldhaber, Nicolas Méneveau et al. profile →

Peers

Countries citing papers authored by Gregory Piazza

Since Specialization

Citations

This map shows the geographic impact of Gregory Piazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Piazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Piazza more than expected).

Fields of papers citing papers by Gregory Piazza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Piazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Piazza. The network helps show where Gregory Piazza may publish in the future.

Co-authorship network of co-authors of Gregory Piazza

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Piazza. A scholar is included among the top collaborators of Gregory Piazza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Piazza. Gregory Piazza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pulmonary Embolism–Related Mortality in Patients With Cancer 2025 ·JAMA Network Open ·Marco Zuin, (unknown), Stanislav Henkin, (unknown), (unknown), Gregory Piazza	3
2	Love for lysis in the time of catheters: is it time to resurrect an old standby? 2025 ·Journal of Thrombosis and Haemostasis ·Stanislav Henkin, Gregory Piazza	1
3	Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes 2025 ·Journal of the American College of Cardiology ·Behnood Bikdeli, Francisco Ujueta, Sina Rashedi, Azita H. Talasaz, Kushal T. Kadakia, (unknown), (unknown), Philippe Gabríel Steg, Gregory Piazza, Rasha Al‐Lamee, David J. Cohen, Roxana Mehran, Harlan M. Krumholz	1
4	Prevalence and Prognostic Relevance of Central Pulmonary Embolism: Systematic Review and Meta-Analysis 2025 ·Archivos de Bronconeumología ·(unknown), J.A. Velarde-Ruiz Velasco, (unknown), Ignacio Jara, (unknown), (unknown), Gema Díaz, Gregory Piazza, Behnood Bikdeli, David Jiménez	0
5	Trends in Sudden Cardiac Death Among Adults Aged 25 to 44 Years in the United States: An Analysis of 2 Large US Databases 2024 ·Journal of the American Heart Association ·Marco Zuin, Sanghamitra Mohanty, Rahul Aggarwal, Matteo Bertini, Behnood Bikdeli, (unknown), (unknown), Andrea Natale, Giuseppe Boriani, Gregory Piazza	6
6	External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry 2024 ·Thrombosis Research ·Romain Chopard, Laurent Bertoletti, Gregory Piazza, David Jiménez, Giovanni Barillari, Pilar Llamas, (unknown), (unknown), Manuel Monréal, Nicolas Méneveau	2
7	Standard- versus extended-duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients 2024 ·Cochrane Database of Systematic Reviews ·Ahmed A. Kolkailah, (unknown), Farida Elshafeey, (unknown), Menna Kamel, (unknown), Ashraf Nabhan, Gregory Piazza	0
8	Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial 2023 ·Circulation ·Gregory Piazza, Alex C. Spyropoulos, Judith Hsia, Mark Goldin, William Towner, Alan S. Go, Todd M. Bull, Stephen Weng, Concetta Lipardi, Elliot S. Barnathan, Marc P. Bonaca, (unknown)	15
9	Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials 2023 ·Thrombosis and Haemostasis ·Judith Hsia, Alex C. Spyropoulos, Gregory Piazza, Stephen Weng, Michael W. Dunne, Concetta Lipardi, Elliot S. Barnathan, Marc P. Bonaca	1
10	Extended Anticoagulation After Pulmonary Embolism: A Multicenter Observational Cohort Analysis 2022 ·Journal of the American Heart Association ·Romain Chopard, Ida Ehlers Albertsen, Fiona Ecarnot, (unknown), Matthieu Besutti, Nicolas Falvo, Gregory Piazza, Nicolas Méneveau	11
11	Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team 2022 ·Journal of Thrombosis and Thrombolysis ·Romain Chopard, Umberto Campia, Lucas Morin, Karola Jering, Zaid Almarzooq, Julia Snyder, (unknown), Aaron B. Waxman, Samuel Z. Goldhaber, Gregory Piazza	11
12	Arterial Thrombotic Complications in COVID-19: A Case of Renal Infarction 2022 ·Biomedicines ·Mariangela Mancini, (unknown), Gregory Piazza, Fabrizio Moro	3
13	The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study 2022 ·Journal of Thrombosis and Haemostasis ·Thure Filskov Overvad, Flemming Skjøth, Gregory Piazza, Simon Noble, Anne Gulbech Ording, Torben Bjerregaard Larsen, Peter Brønnum Nielsen	19
14	Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable 2022 ·IJC Heart & Vasculature ·Geoffrey D. Barnes, (unknown), Gregory Piazza, (unknown), (unknown), Tze‐Fan Chao, Mario Njeim, Kian Keong Poh, Leandro Ioschpe Zimerman	3
15	Loss of Pulmonary Vascular Volume as a Predictor of Right Ventricular Dysfunction and Mortality in Acute Pulmonary Embolism 2021 ·Circulation Cardiovascular Imaging ·Jasleen Minhas, Pietro Nardelli, (unknown), Nadine Al‐Naamani, Eileen M. Harder, Samuel Y. Ash, Gonzalo Vegas‐Sánchez‐Ferrero, Stefanie Mason, Andetta R. Hunsaker, Gregory Piazza, Samuel Z. Goldhaber, Aaron B. Waxman, Steven M. Kawut, Raúl San Jośe Estépar, George R. Washko, Farbod N. Rahaghi	14
16	Surgical pulmonary embolectomy and catheter-directed thrombolysis for treatment of submassive pulmonary embolism 2018 ·Journal of Cardiac Surgery ·Ahmed A. Kolkailah, Sameer Hirji, Gregory Piazza, Julius I. Ejiofor, (unknown), (unknown), Siobhan McGurk, Sary F. Aranki, Prem Shekar, Tsuyoshi Kaneko	21
17	Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis 2017 ·Circulation ·Ilaria Cavallari, David A. Morrow, Mark A. Creager, Jeffrey W. Olin, Deepak L. Bhatt, Philippe Gabríel Steg, Robert F. Storey, Marc Cohen, (unknown), Gregory Piazza, Erica L. Goodrich, Eugene Braunwald, Marc S. Sabatine, Marc P. Bonaca	26
18	Warfarin Versus Novel Oral Anticoagulants 2014 ·Circulation ·Rishi K. Wadhera, (unknown), Gregory Piazza	49
19	Dabigatran 2011 ·Critical Pathways in Cardiology A Journal of Evidence-Based Medicine ·Prabashni Reddy, (unknown), (unknown), Jean M. Connors, Gregory Piazza, Caroline Block, Paul A. Arpino, Nancy Berliner, Adolph M. Hutter, Michael A. Fischer, David J. Kuter, (unknown), (unknown), (unknown), Robert P. Giugliano	11
20	Correlates of Bleeding Events Among Moderate- to High-Risk Patients Undergoing Percutaneous Coronary Intervention and Treated With Eptifibatide 2006 ·Journal of the American College of Cardiology ·Ajay J. Kirtane, Gregory Piazza, Sabina A. Murphy, (unknown), David A. Morrow, (unknown), Eric D. Peterson, Nasser Lakkis, Howard C. Herrmann, Theresa M. Palabrica, C. Michael Gibson	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact